Search Results - "Voss, H."

Human consciousness is supported by dynamic complex patterns of brain signal coordination by Demertzi, A, Tagliazucchi, E, Dehaene, S, Deco, G, Barttfeld, P, Raimondo, F, Martial, C, Fernández-Espejo, D, Rohaut, B, Voss, H U, Schiff, N D, Owen, A M, Laureys, S, Naccache, L, Sitt, J D

“…Adopting the framework of brain dynamics as a cornerstone of human consciousness, we determined whether dynamic signal coordination provides specific and…”
Get full text

A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants by Mathew, James M., H.-Voss, Jessica, LeFever, Ann, Konieczna, Iwona, Stratton, Cheryl, He, Jie, Huang, Xuemei, Gallon, Lorenzo, Skaro, Anton, Ansari, Mohammed Javeed, Leventhal, Joseph R.

“…There is considerable interest in therapeutic transfer of regulatory T cells (Tregs) for controlling aberrant immune responses. Initial clinical trials have…”
Get full text

Towards individualized therapy for metastatic renal cell carcinoma by Kotecha, Ritesh R., Motzer, Robert J., Voss, Martin H.

“…Over the past decade, the treatment landscape for patients with metastatic renal cell carcinoma (RCC) has evolved dramatically. The therapeutic options…”
Get full text

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma by Miao, Diana, Margolis, Claire A, Gao, Wenhua, Voss, Martin H, Li, Wei, Martini, Dylan J, Norton, Craig, Bossé, Dominick, Wankowicz, Stephanie M, Cullen, Dana, Horak, Christine, Wind-Rotolo, Megan, Tracy, Adam, Giannakis, Marios, Hodi, Frank Stephen, Drake, Charles G, Ball, Mark W, Allaf, Mohamad E, Snyder, Alexandra, Hellmann, Matthew D, Ho, Thai, Motzer, Robert J, Signoretti, Sabina, Kaelin, Jr, William G, Choueiri, Toni K, Van Allen, Eliezer M

“…Immune checkpoint inhibitors targeting the programmed cell death 1 receptor (PD-1) improve survival in a subset of patients with clear cell renal cell…”
Get full text

Light subgraphs of graphs embedded in the plane—A survey by Jendrol’, S., Voss, H.-J.

“…It is well known that every planar graph contains a vertex of degree at most 5. A theorem of Kotzig states that every 3-connected planar graph contains an edge…”
Get full text

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures by Şenbabaoğlu, Yasin, Gejman, Ron S, Winer, Andrew G, Liu, Ming, Van Allen, Eliezer M, de Velasco, Guillermo, Miao, Diana, Ostrovnaya, Irina, Drill, Esther, Luna, Augustin, Weinhold, Nils, Lee, William, Manley, Brandon J, Khalil, Danny N, Kaffenberger, Samuel D, Chen, Yingbei, Danilova, Ludmila, Voss, Martin H, Coleman, Jonathan A, Russo, Paul, Reuter, Victor E, Chan, Timothy A, Cheng, Emily H, Scheinberg, David A, Li, Ming O, Choueiri, Toni K, Hsieh, James J, Sander, Chris, Hakimi, A Ari

“…Tumor-infiltrating immune cells have been linked to prognosis and response to immunotherapy; however, the levels of distinct immune cell subsets and the…”
Get full text

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3‐Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma by Carlo, Maria I., Molina, Ana M., Lakhman, Yulia, Patil, Sujata, Woo, Kaitlin, DeLuca, John, Lee, Chung‐Han, Hsieh, James J., Feldman, Darren R., Motzer, Robert J., Voss, Martin H.

“…Lessons Learned Our results highlight additional toxicities of dual PI3K/mTOR inhibition in the clinical setting that were unforeseen from preclinical models…”
Get full text

Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial by Hakimi, A Ari, Voss, Martin H, Kuo, Fengshen, Sanchez, Alejandro, Liu, Ming, Nixon, Briana G, Vuong, Lynda, Ostrovnaya, Irina, Chen, Ying-Bei, Reuter, Victor, Riaz, Nadeem, Cheng, Yuan, Patel, Parul, Marker, Mahtab, Reising, Albert, Li, Ming O, Chan, Timothy A, Motzer, Robert J

“…Metastasis remains the main reason for renal cell carcinoma (RCC)-associated mortality. Tyrosine kinase inhibitors (TKI) impart clinical benefit for most…”
Get more information

Effect of Dwarfing Rht Genes on Fusarium Head Blight Resistance in Two Sets of Near-Isogenic Lines of Wheat and Check Cultivars by Miedaner, T, Voss, H.H

“…Reduced height (Rht) genes are used in wheat (Triticum aestivum L.) breeding throughout the world. Fusarium head blight (FHB) is one of the most destructive…”
Get full text

Novel emerging biomarkers to immunotherapy in kidney cancer by Ged, Yasser, Voss, Martin H.

“…The treatment of metastatic renal cell carcinoma has significantly evolved in recent years, particularly with the advent of novel immune checkpoint inhibitors…”
Get full text

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) by Rini, Brian I., Battle, Dena, Figlin, Robert A., George, Daniel J., Hammers, Hans, Hutson, Tom, Jonasch, Eric, Joseph, Richard W., McDermott, David F., Motzer, Robert J., Pal, Sumanta K., Pantuck, Allan J., Quinn, David I., Seery, Virginia, Voss, Martin H., Wood, Christopher G., Wood, Laura S., Atkins, Michael B.

“…The approval of immunotherapeutic agents and immunotherapy-based combination strategies in recent years has revolutionized the treatment of patients with…”
Get full text

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma by Gleeson, Jack P, Nikolovski, Ines, Dinatale, Renzo, Zucker, Mark, Knezevic, Andrea, Patil, Sujata, Ged, Yasser, Kotecha, Ritesh R, Shapnik, Natalie, Murray, Samuel, Russo, Paul, Coleman, Jonathan, Lee, Chung Han, Stadler, Zsofia K, Hakimi, A Ari, Feldman, Darren R, Motzer, Robert J, Reznik, Ed, Voss, Martin H, Chen, Ying-Bei, Carlo, Maria I

“…Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a rare, aggressive form of RCC associated with hereditary leiomyomatosis and RCC syndrome…”
Get full text

An Arnoldi method for nonlinear eigenvalue problems by VOSS, H

Get full text

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response by Hakimi, A. Ari, Attalla, Kyrollis, DiNatale, Renzo G., Ostrovnaya, Irina, Flynn, Jessica, Blum, Kyle A., Ged, Yasser, Hoen, Douglas, Kendall, Sviatoslav M., Reznik, Ed, Bowman, Anita, Hwee, Jason, Fong, Christopher J., Kuo, Fengshen, Voss, Martin H., Chan, Timothy A., Motzer, Robert J.

“…There is conflicting data regarding the role of PBAF complex mutations and response to immune checkpoint blockade (ICB) therapy in clear cell renal cell…”
Get full text

Caspase-11 Promotes the Fusion of Phagosomes Harboring Pathogenic Bacteria with Lysosomes by Modulating Actin Polymerization by Akhter, Anwari, Caution, Kyle, Abu Khweek, Arwa, Tazi, Mia, Abdulrahman, Basant A., Abdelaziz, Dalia H.A., Voss, Oliver H., Doseff, Andrea I., Hassan, Hoda, Azad, Abul K., Schlesinger, Larry S., Wewers, Mark D., Gavrilin, Mikhail A., Amer, Amal O.

“…Inflammasomes are multiprotein complexes that include members of the NLR (nucleotide-binding domain leucine-rich repeat containing) family and caspase-1. Once…”
Get full text

Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma by Carlo, Maria I., Voss, Martin H., Motzer, Robert J.

“…Key Points Checkpoint inhibitors have shown promising efficacy and manageable safety profiles for patients with advanced renal cell carcinoma (RCC) The…”
Get full text

Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets by Chen, Ying-Bei, Xu, Jianing, Skanderup, Anders Jacobsen, Dong, Yiyu, Brannon, A. Rose, Wang, Lu, Won, Helen H., Wang, Patricia I., Nanjangud, Gouri J., Jungbluth, Achim A., Li, Wei, Ojeda, Virginia, Hakimi, A. Ari, Voss, Martin H., Schultz, Nikolaus, Motzer, Robert J., Russo, Paul, Cheng, Emily H., Giancotti, Filippo G., Lee, William, Berger, Michael F., Tickoo, Satish K., Reuter, Victor E., Hsieh, James J.

“…Renal cell carcinomas with unclassified histology (uRCC) constitute a significant portion of aggressive non-clear cell renal cell carcinomas that have no…”
Get full text

Crust and uppermost-mantle structure of Greenland and the Northwest Atlantic from Rayleigh wave group velocity tomography by Darbyshire, Fiona A, Dahl-Jensen, Trine, Larsen, Tine B, Voss, Peter H, Joyal, Guillaume

“…Summary The Greenland landmass preserves ∼4 billion years of tectonic history, but much of the continent is inaccessible to geological study due to the…”
Get full text

Inception of institutionalization of clinical neurology in Munich (1913-1933): with particular focus on Eugen von Malaisé by Voss, H

“…At the University of Munich the teaching and treatment of neurological diseases had been covered by internists since the last quarter of the nineteenth…”
Get full text

Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma by Hakimi, A. Ari, Chen, Ying-Bei, Wren, James, Gonen, Mithat, Abdel-Wahab, Omar, Heguy, Adriana, Liu, Han, Takeda, Shugaku, Tickoo, Satish K, Reuter, Victor E, Voss, Martin H, Motzer, Robert J, Coleman, Jonathan A, Cheng, Emily H, Russo, Paul, Hsieh, James J

“…Abstract Background Historically, VHL was the only frequently mutated gene in clear cell renal cell carcinoma (ccRCC), with conflicting clinical relevance…”
Get full text